{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:46:25Z","timestamp":1789055185810,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CIBERES","award":["CB06\/06\/0028"],"award-info":[{"award-number":["CB06\/06\/0028"]}]},{"name":"Research Groups of Catalonia 911","award":["Research Groups of Catalonia 911"],"award-info":[{"award-number":["Research Groups of Catalonia 911"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"DOI":"10.1186\/s41479-025-00185-9","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:02:30Z","timestamp":1764892950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Corticosteroids and hospital-acquired pneumonia"],"prefix":"10.1186","volume":"17","author":[{"given":"Lucia Alessandra","family":"Pasqua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catia","family":"Cilloniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"185_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63:e61. https:\/\/doi.org\/10.1093\/cid\/ciw353.","journal-title":"Clin Infect Dis"},{"key":"185_CR2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres A, Niederman MS, Chastre J, et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European respiratory society (ERS), European society of intensive care medicine (ESICM), European society of clinical microbiology and infectious diseases (ESCMID) and Asociaci\u00f3n Latinoamericana Del T\u00f3rax (ALAT). Eur Respir J. 2017;50:1700582. https:\/\/doi.org\/10.1183\/13993003.00582-2017.","journal-title":"Eur Respir J"},{"key":"185_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0023-2020","volume":"29","author":"MS Vallecoccia","year":"2020","unstructured":"Vallecoccia MS, Domined\u00f2 C, Cutuli SL, et al. Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? Eur Respir Rev. 2020;29:200023. https:\/\/doi.org\/10.1183\/16000617.0023-2020.","journal-title":"Eur Respir Rev"},{"key":"185_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1055\/s-0041-1740246","volume":"43","author":"P-H Wicky","year":"2022","unstructured":"Wicky P-H, Martin-Loeches I, Timsit J-F. HAP and VAP after guidelines. Semin Respir Crit Care Med. 2022;43:248\u201354. https:\/\/doi.org\/10.1055\/s-0041-1740246.","journal-title":"Semin Respir Crit Care Med"},{"key":"185_CR5","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1097\/CCM.0b013e318259203d","volume":"40","author":"OT Ranzani","year":"2012","unstructured":"Ranzani OT, Ferrer M, Esperatti M, et al. Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia. Crit Care Med. 2012;40:2552\u201361. https:\/\/doi.org\/10.1097\/CCM.0b013e318259203d.","journal-title":"Crit Care Med"},{"key":"185_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1183\/09031936.00009208","volume":"32","author":"O Sibila","year":"2008","unstructured":"Sibila O, Luna CM, Agust\u00ed C, et al. Effects of glucocorticoids in ventilated piglets with severe pneumonia. Eur Respir J. 2008;32:1037\u201346. https:\/\/doi.org\/10.1183\/09031936.00009208.","journal-title":"Eur Respir J"},{"key":"185_CR7","unstructured":"Global report on infection prevention and control. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240103986. Accessed 29 Mar 2025."},{"key":"185_CR8","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","volume":"379","author":"SS Magill","year":"2018","unstructured":"Magill SS, O\u2019Leary E, Janelle SJ, et al. Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med. 2018;379:1732\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1801550.","journal-title":"N Engl J Med"},{"key":"185_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00259-0","volume":"7","author":"A Torres","year":"2021","unstructured":"Torres A, Cilloniz C, Niederman MS, et al. Pneumonia. Nat Rev Dis Primers. 2021;7:25. https:\/\/doi.org\/10.1038\/s41572-021-00259-0.","journal-title":"Nat Rev Dis Primers"},{"key":"185_CR10","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.32.1700843","volume":"23","author":"J Walter","year":"2018","unstructured":"Walter J, Haller S, Quinten C, et al. Healthcare-associated pneumonia in acute care hospitals in European Union\/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012. Euro Surveill. 2018;23:1700843. https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.32.1700843.","journal-title":"Euro Surveill"},{"key":"185_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03460-5","volume":"25","author":"M Maes","year":"2021","unstructured":"Maes M, Higginson E, Pereira-Dias J, et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care. 2021;25:25. https:\/\/doi.org\/10.1186\/s13054-021-03460-5.","journal-title":"Crit Care"},{"key":"185_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.idh.2024.07.004","volume":"30","author":"G De Souza Dos Santos","year":"2025","unstructured":"De Souza Dos Santos G, Alves de Carvalho Fran\u00e7a de Macedo V, Oliniski Reikdal S, et al. Ventilator-associated pneumonia risk factors in patients with severe COVID-19 in Southern brazil: A retrospective observational study. Infect Dis Health. 2025;30:38\u201349. https:\/\/doi.org\/10.1016\/j.idh.2024.07.004.","journal-title":"Infect Dis Health"},{"key":"185_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14020127","volume":"14","author":"LF Reyes","year":"2025","unstructured":"Reyes LF, Torres A, Olivella-Gomez J, et al. Factors associated with mortality in nosocomial lower respiratory tract infections: an ENIRRI analysis. Antibiotics. 2025;14:127. https:\/\/doi.org\/10.3390\/antibiotics14020127.","journal-title":"Antibiotics"},{"key":"185_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/s-0041-1740605","volume":"43","author":"M Bassetti","year":"2022","unstructured":"Bassetti M, Mularoni A, Giacobbe DR, et al. New antibiotics for hospital-acquired pneumonia and ventilator-associated pneumonia. Semin Respir Crit Care Med. 2022;43:280\u201394. https:\/\/doi.org\/10.1055\/s-0041-1740605.","journal-title":"Semin Respir Crit Care Med"},{"key":"185_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02779-1","volume":"25","author":"G Montrucchio","year":"2024","unstructured":"Montrucchio G, Balzani E, Sales G, et al. Multidrug-resistant pathogens and ventilator-associated pneumonia in critically ill COVID-19 and non-COVID-19 patients: a prospective observational monocentric comparative study. Respir Res. 2024;25:168. https:\/\/doi.org\/10.1186\/s12931-024-02779-1.","journal-title":"Respir Res"},{"key":"185_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jiac.2022.02.012","volume":"28","author":"M Sano","year":"2022","unstructured":"Sano M, Shindo Y, Takahashi K, et al. Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia. J Infect Chemother. 2022;28:745\u201352. https:\/\/doi.org\/10.1016\/j.jiac.2022.02.012.","journal-title":"J Infect Chemother"},{"key":"185_CR17","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40121-023-00820-2","volume":"12","author":"A Alnimr","year":"2023","unstructured":"Alnimr A. Antimicrobial resistance in ventilator-associated pneumonia: predictive microbiology and evidence-based therapy. Infect Dis Ther. 2023;12:1527\u201352. https:\/\/doi.org\/10.1007\/s40121-023-00820-2.","journal-title":"Infect Dis Ther"},{"key":"185_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.12688\/f1000research.129080.1","volume":"12","author":"D Hammoudi Halat","year":"2023","unstructured":"Hammoudi Halat D, Ayoub Moubareck C. Hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19. F1000Res. 2023;12:92. https:\/\/doi.org\/10.12688\/f1000research.129080.1.","journal-title":"F1000Res"},{"key":"185_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007720.pub3","volume":"2017","author":"A Stern","year":"2017","unstructured":"Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017;2017:CD007720. https:\/\/doi.org\/10.1002\/14651858.CD007720.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"185_CR20","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.12998\/wjcc.v10.i21.7187","volume":"10","author":"W-Y Jia","year":"2022","unstructured":"Jia W-Y, Zhang J-J. Effects of glucocorticoids on leukocytes: genomic and non-genomic mechanisms. World J Clin Cases. 2022;10:7187\u201394. https:\/\/doi.org\/10.12998\/wjcc.v10.i21.7187.","journal-title":"World J Clin Cases"},{"key":"185_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/CPM.0000000000000102","volume":"22","author":"OT Ranzani","year":"2015","unstructured":"Ranzani OT, Zampieri FG, Caruso P, Torres A. Corticosteroids in the critically ill patient: benefits and risks for hospital-acquired pneumonia\/ventilator-associated pneumonia. Clin Pulm Med. 2015;22:215\u201322. https:\/\/doi.org\/10.1097\/CPM.0000000000000102.","journal-title":"Clin Pulm Med"},{"key":"185_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s00134-022-06726-w","volume":"48","author":"A Torres","year":"2022","unstructured":"Torres A, Motos A, Cill\u00f3niz C, et al. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study. Intensive Care Med. 2022;48:850\u201364. https:\/\/doi.org\/10.1007\/s00134-022-06726-w.","journal-title":"Intensive Care Med"},{"key":"185_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04170-2","volume":"26","author":"O Saura","year":"2022","unstructured":"Saura O, Rouz\u00e9 A, Martin-Loeches I, et al. Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study. Crit Care. 2022;26:292. https:\/\/doi.org\/10.1186\/s13054-022-04170-2.","journal-title":"Crit Care"},{"key":"185_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/jcan.2003.4","volume":"17","author":"M Pawar","year":"2003","unstructured":"Pawar M, Mehta Y, Khurana P, et al. Ventilator-associated pneumonia: incidence, risk factors, outcome, and microbiology. J Cardiothorac Vasc Anesth. 2003;17:22\u20138. https:\/\/doi.org\/10.1053\/jcan.2003.4.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"185_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04097-8","volume":"26","author":"P Lamouche-Wilquin","year":"2022","unstructured":"Lamouche-Wilquin P, Souchard J, Pere M, et al. Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS. Crit Care. 2022;26:233. https:\/\/doi.org\/10.1186\/s13054-022-04097-8.","journal-title":"Crit Care"},{"key":"185_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03654-x","volume":"25","author":"M Mart\u00ednez-Mart\u00ednez","year":"2021","unstructured":"Mart\u00ednez-Mart\u00ednez M, Plata-Menchaca EP, Nuvials FX, et al. Risk factors and outcomes of ventilator-associated pneumonia in COVID-19 patients: a propensity score matched analysis. Crit Care. 2021;25:235. https:\/\/doi.org\/10.1186\/s13054-021-03654-x.","journal-title":"Crit Care"},{"key":"185_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154014","volume":"69","author":"LF Reyes","year":"2022","unstructured":"Reyes LF, Rodriguez A, Bastidas A, et al. Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19. J Crit Care. 2022;69:154014. https:\/\/doi.org\/10.1016\/j.jcrc.2022.154014.","journal-title":"J Crit Care"},{"key":"185_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00134-010-2078-z","volume":"37","author":"I Martin-Loeches","year":"2011","unstructured":"Martin-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med. 2011;37:272\u201383. https:\/\/doi.org\/10.1007\/s00134-010-2078-z.","journal-title":"Intensive Care Med"},{"key":"185_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MJT.0b013e3182691af0","volume":"22","author":"A Chaari","year":"2015","unstructured":"Chaari A, El Habib M, Ghdhoun H, et al. Does low-dose hydrocortisone therapy prevent ventilator-associated pneumonia in trauma patients? Am J Ther. 2015;22:22\u20138. https:\/\/doi.org\/10.1097\/MJT.0b013e3182691af0.","journal-title":"Am J Ther"},{"key":"185_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1177\/08850666211032175","volume":"36","author":"LA Ritter","year":"2021","unstructured":"Ritter LA, Britton N, Heil EL, et al. The impact of corticosteroids on secondary infection and mortality in critically ill COVID-19 patients. J Intensive Care Med. 2021;36:1201\u20138. https:\/\/doi.org\/10.1177\/08850666211032175.","journal-title":"J Intensive Care Med"},{"key":"185_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00876-8","volume":"11","author":"I Gragueb-Chatti","year":"2021","unstructured":"Gragueb-Chatti I, Lopez A, Hamidi D, et al. Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study. Ann Intensive Care. 2021;11:87. https:\/\/doi.org\/10.1186\/s13613-021-00876-8.","journal-title":"Ann Intensive Care"},{"key":"185_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09909-6","volume":"24","author":"M Elsheikh","year":"2024","unstructured":"Elsheikh M, Kuriyama A, Goto Y, et al. Incidence and predictors of ventilator-associated pneumonia using a competing risk analysis: a single-center prospective cohort study in Egypt. BMC Infect Dis. 2024;24:1007. https:\/\/doi.org\/10.1186\/s12879-024-09909-6.","journal-title":"BMC Infect Dis"},{"key":"185_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1001\/jama.2011.360","volume":"305","author":"A Roquilly","year":"2011","unstructured":"Roquilly A, Mahe PJ, Seguin P, et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA. 2011;305:1201\u20139. https:\/\/doi.org\/10.1001\/jama.2011.360.","journal-title":"JAMA"},{"key":"185_CR34","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa051693","volume":"354","author":"KP Steinberg","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671\u201384. https:\/\/doi.org\/10.1056\/NEJMoa051693.","journal-title":"N Engl J Med"},{"key":"185_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-024-00146-8","volume":"16","author":"C Cilloniz","year":"2024","unstructured":"Cilloniz C, Guzzardella A, Calabretta D, et al. Outcomes of corticosteroid therapy in patients with viral community-acquired pneumonia. Pneumonia. 2024;16:21. https:\/\/doi.org\/10.1186\/s41479-024-00146-8.","journal-title":"Pneumonia"},{"key":"185_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04049-2","volume":"26","author":"V Scaravilli","year":"2022","unstructured":"Scaravilli V, Guzzardella A, Madotto F, et al. Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study. Crit Care. 2022;26:176. https:\/\/doi.org\/10.1186\/s13054-022-04049-2.","journal-title":"Crit Care"},{"key":"185_CR37","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1017\/S0950268812001604","volume":"141","author":"SB Hong","year":"2013","unstructured":"Hong SB, Choi EY, Kim SH, et al. Epidemiological analysis of critically ill adult patients with pandemic influenza A(H1N1) in South Korea. Epidemiol Infect. 2013;141:1070\u20139. https:\/\/doi.org\/10.1017\/S0950268812001604.","journal-title":"Epidemiol Infect"},{"key":"185_CR38","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","volume":"48","author":"LE Lansbury","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, et al. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and Meta-analysis. Crit Care Med. 2020;48:e98\u2013106. https:\/\/doi.org\/10.1097\/CCM.0000000000004093.","journal-title":"Crit Care Med"},{"key":"185_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59732-7","volume":"10","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Fu X, Liu X, et al. Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis. Sci Rep. 2020;10:3044. https:\/\/doi.org\/10.1038\/s41598-020-59732-7.","journal-title":"Sci Rep"},{"key":"185_CR40","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","volume":"44","author":"G Moreno","year":"2018","unstructured":"Moreno G, Rodr\u00edguez A, Reyes LF, et al. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med. 2018;44:1470\u201382. https:\/\/doi.org\/10.1007\/s00134-018-5332-4.","journal-title":"Intensive Care Med"},{"key":"185_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2024.6096","volume":"332","author":"R Pirracchio","year":"2024","unstructured":"Pirracchio R, Venkatesh B, Legrand M. Low-dose corticosteroids for critically ill adults with severe pulmonary infections: a review. JAMA. 2024;332:318\u201328. https:\/\/doi.org\/10.1001\/jama.2024.6096.","journal-title":"JAMA"},{"key":"185_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S2213-2600(14)70144-4","volume":"2","author":"K Asehnoune","year":"2014","unstructured":"Asehnoune K, Seguin P, Allary J, et al. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir Med. 2014;2:706\u201316. https:\/\/doi.org\/10.1016\/S2213-2600(14)70144-4.","journal-title":"Lancet Respir Med"},{"key":"185_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.hrtlng.2025.01.002","volume":"70","author":"S-J Abi-Aad","year":"2025","unstructured":"Abi-Aad S-J, Eid H, Harmouche C, et al. ICU-acquired superinfections before and during the COVID-19 pandemic: similarities and differences. Heart Lung. 2025;70:298\u2013304. https:\/\/doi.org\/10.1016\/j.hrtlng.2025.01.002.","journal-title":"Heart Lung"},{"key":"185_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jinf.2022.05.015","volume":"85","author":"S S\u00f8vik","year":"2022","unstructured":"S\u00f8vik S, Barrat-Due A, K\u00e5sine T, et al. Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation. J Infect. 2022;85:57\u201363. https:\/\/doi.org\/10.1016\/j.jinf.2022.05.015.","journal-title":"J Infect"},{"key":"185_CR45","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jamainternmed.2022.2168","volume":"182","author":"L Bouadma","year":"2022","unstructured":"Bouadma L, Mekontso-Dessap A, Burdet C, et al. High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: the COVIDICUS randomized clinical trial. JAMA Intern Med. 2022;182:906\u201316. https:\/\/doi.org\/10.1001\/jamainternmed.2022.2168.","journal-title":"JAMA Intern Med"},{"key":"185_CR46","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1001\/jama.2021.18295","volume":"326","author":"The COVID STEROID 2 Trial Group","year":"2021","unstructured":"The COVID STEROID 2 Trial Group. Effect of 12\u00a0mg vs 6\u00a0mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial. JAMA. 2021;326:1807\u201317. https:\/\/doi.org\/10.1001\/jama.2021.18295.","journal-title":"JAMA"},{"key":"185_CR47","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1164\/ajrccm.150.6.7952612","volume":"150","author":"J Rello","year":"1994","unstructured":"Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 1994;150:1545\u20139. https:\/\/doi.org\/10.1164\/ajrccm.150.6.7952612.","journal-title":"Am J Respir Crit Care Med"},{"key":"185_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/infdis\/144.1.19","volume":"144","author":"F Espersen","year":"1981","unstructured":"Espersen F, Gabrielsen J. Pneumonia due to Staphylococcus aureus during mechanical ventilation. J Infect Dis. 1981;144:19\u201323. https:\/\/doi.org\/10.1093\/infdis\/144.1.19.","journal-title":"J Infect Dis"},{"key":"185_CR49","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1164\/rccm.201101-0110OC","volume":"183","author":"S-H Kim","year":"2011","unstructured":"Kim S-H, Hong S-B, Yun S-C, et al. Corticosteroid treatment in critically ill patients with pandemic influenza A\/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med. 2011;183:1207\u201314. https:\/\/doi.org\/10.1164\/rccm.201101-0110OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"185_CR50","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1086\/422641","volume":"39","author":"FHY Yap","year":"2004","unstructured":"Yap FHY, Gomersall CD, Fung KSC, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis. 2004;39:511\u20136. https:\/\/doi.org\/10.1086\/422641.","journal-title":"Clin Infect Dis"},{"key":"185_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020360","volume":"13","author":"A Rodr\u00edguez","year":"2025","unstructured":"Rodr\u00edguez A, Berrueta J, P\u00e1ez C, et al. Ten-year evaluation of ventilator-associated pneumonia (VAP) according to initial empiric treatment: a retrospective analysis using real-world data. Biomedicines. 2025;13:360. https:\/\/doi.org\/10.3390\/biomedicines13020360.","journal-title":"Biomedicines"},{"key":"185_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010028","volume":"14","author":"M Stoian","year":"2025","unstructured":"Stoian M, Andone A, B\u00e2ndil\u0103 SR, et al. Mechanical ventilator-associated pneumonia in the COVID-19 pandemic era: a critical challenge in the intensive care units. Antibiotics. 2025;14:28. https:\/\/doi.org\/10.3390\/antibiotics14010028.","journal-title":"Antibiotics"},{"key":"185_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037419","volume":"10","author":"L Li","year":"2020","unstructured":"Li L, Hsu SH, Gu X, et al. Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study. BMJ Open. 2020;10:e037419. https:\/\/doi.org\/10.1136\/bmjopen-2020-037419.","journal-title":"BMJ Open"},{"key":"185_CR54","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1378\/chest.123.2.488","volume":"123","author":"C Agust\u00ed","year":"2003","unstructured":"Agust\u00ed C, Ra\u00f1\u00f3 A, Filella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response. Chest. 2003;123:488\u201398. https:\/\/doi.org\/10.1378\/chest.123.2.488.","journal-title":"Chest"},{"key":"185_CR55","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1183\/09031936.95.08111929","volume":"8","author":"ML Pedro-Botet","year":"1995","unstructured":"Pedro-Botet ML, Sabria-Leal M, Haro M, et al. Nosocomial and community-acquired Legionella pneumonia: clinical comparative analysis. Eur Respir J. 1995;8:1929\u201333. https:\/\/doi.org\/10.1183\/09031936.95.08111929.","journal-title":"Eur Respir J"},{"key":"185_CR56","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1164\/ajrccm.149.3.8118629","volume":"149","author":"J Carratala","year":"1994","unstructured":"Carratala J, Gudiol F, Pallares R, et al. Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med. 1994;149:625\u20139. https:\/\/doi.org\/10.1164\/ajrccm.149.3.8118629.","journal-title":"Am J Respir Crit Care Med"},{"key":"185_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ecdt.ecdt_8_24","volume":"74","author":"SMM Wafy","year":"2025","unstructured":"Wafy SMM, Bayoumi HA-EH, Hassan RH. Randomized controlled trial: the safety and efficacy of adjunctive corticosteroids through the clinical course of severe hospital-acquired pneumonia. Egypt J Chest Dis Tuberculosis. 2025;74:95. https:\/\/doi.org\/10.4103\/ecdt.ecdt_8_24.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"key":"185_CR58","unstructured":"Nantes University Hospital. Dexamethasone for treating severe Hospital-acquired pneumonia in critically ill patients with a Proinflammatory Phenotype, an international phase III, Double-blind, Placebo-controlled, Randomized Trial. (NCT06269900). 2024. Retrieved July 7, 2025, from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06269900."}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-025-00185-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:02:31Z","timestamp":1764892951000},"score":1,"resource":{"primary":{"URL":"https:\/\/pneumonia.biomedcentral.com\/articles\/10.1186\/s41479-025-00185-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1186\/s41479-025-00185-9","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}